GLP-1
-
healthGLP-1 Medications Linked to Improved Male Fertility and Testosterone Levels
New research presented at ENDO 2026 suggests GLP-1 weight-loss drugs may improve testosterone and sperm quality in obese men, offering a fertility-preserving alternative to traditional hormone replacement therapy.
-
healthGLP-1 Weight Loss Drugs Drive Surge in Cosmetic Body Contouring Procedures
Rapid weight loss from GLP-1 medications like Ozempic is causing sagging skin and volume loss, prompting a significant increase in plastic surgery and body contouring procedures nationwide.
-
healthUK Approves First Daily Oral GLP-1 Semaglutide for Obesity Treatment
Novo Nordisk secures UK approval for daily oral semaglutide, offering a non-injectable alternative for obesity management with significant weight loss results in clinical trials.
-
healthCanada Faces Critical Whey Protein Shortage Amid Surging Demand and Supply Constraints
A perfect storm of GLP-1 drug usage, mainstream food integration, and Canada's supply management system is driving whey protein costs up by 100%, forcing businesses to pivot.
-
healthGLP-1 Drugs Linked to Lower Breast Cancer Risk and Better Outcomes
Observational studies show GLP-1 meds like Ozempic may reduce breast cancer incidence by 30% and improve survival rates.
-
healthGLP-1 Drugs May Cut Breast Cancer Risk by 30%, Study Finds
GLP-1 medications like Ozempic and Mounjaro may reduce breast cancer risk by up to 30%, independent of weight loss, new research shows.
-
healthGLP-1 Drugs Like Ozempic Show Broad Cancer Protection Promise
Multiple studies at ASCO 2024 show GLP-1 drugs reduce cancer risk and improve outcomes across tumor types, with potential benefits tied to inflammation reduction and weight loss.
-
healthAI Analysis of Reddit Posts Reveals Potential Hidden Side Effects of Ozempic
Researchers used AI to analyze Reddit posts, uncovering unreported side effects of GLP-1 drugs like Ozempic and Wegovy.